Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from TGF-beta treated Panc-1 pancreatic adenocarcinoma cell line

ABSTRACT: TGF-beta treatment of Panc-1 pancreatic adenocarcinoma cell line on Affymetrix HG_U133_plus_2 arrays; triplicate experiments. The goal of the experiment is to profile temporal gene expression changes during TGF-beta-induced epithelial-mesenchymal transition (EMT). During EMT cancer cells lose their epithelial specifc proteins and gain mesenchymal proteins to acquire migratory and invasive phenotype essential for metastasis. Human Panc-1 pancreatic adenocarcinoma cell line was treated with 5 ng/mL TGF-beta for 48 h to induce EMT. The experiment was repeated 3 times. Samples were assayed using Affymetrix HG_U133_plus_2 arrays with 54675 probe-sets, using standard techniques. Human Panc-1 pancreatic adenocarcinoma cell line was treated with 5 ng/mL TGF-beta for 48 h. The experiment was repeated 3 times. Samples were assayed using Affymetrix HG_U133_plus_2 arrays with 54675 probe-sets, using standard techniques.

ORGANISM(S): Homo sapiens

SUBMITTER: brian haab 

PROVIDER: E-GEOD-23952 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems.

Maupin Kevin A KA   Sinha Arkadeep A   Eugster Emily E   Miller Jeremy J   Ross Julianna J   Paulino Vincent V   Keshamouni Venkateshwar G VG   Tran Nhan N   Berens Michael M   Webb Craig C   Haab Brian B BB  

PloS one 20100927 9

<h4>Background</h4>The ability to selectively detect and target cancer cells that have undergone an epithelial-mesenchymal transition (EMT) may lead to improved methods to treat cancers such as pancreatic cancer. The remodeling of cellular glycosylation previously has been associated with cell differentiation and may represent a valuable class of molecular targets for EMT.<h4>Methodology/principal findings</h4>As a first step toward investigating the nature of glycosylation alterations in EMT, w  ...[more]

Similar Datasets

Transcriptomics Expression data from TGF-beta treated Panc-1 pancreatic adenocarcinoma cell line
2010-09-03 | GSE23952 | GEO
Transcriptomics Transcription profiling of human A549 lung adenocarcinoma cell line time Course of TGF-beta treatment
2009-09-15 | E-GEOD-17708 | biostudies-arrayexpress
Transcriptomics Time Course of TGF-beta treatment of A549 lung adenocarcinoma cell line
2009-08-20 | GSE17708 | GEO
Transcriptomics Human adrenocortical carcinomas (33), adenomas (22), and normal adrenal cortex (10), on Affymetrix HG_U133_plus_2 arrays
2009-01-22 | GSE10927 | GEO
Transcriptomics GSK3B shRNA in Panc-1 xenografts
2014-01-09 | E-GEOD-35351 | biostudies-arrayexpress
Genomics Homo sapiens
| PRJNA130493 | ENA
Transcriptomics TGF-β Tumor Suppression Through A Lethal EMT
2016-02-24 | GSE72069 | GEO
Transcriptomics TGF-β and RREB1 coordinate EMT programs in development and cancer
2020-01-09 | GSE118765 | GEO
Transcriptomics Identification of malignant phenotype related genes in pancreatic ductal adenocarcinoma
2018-08-24 | GSE118556 | GEO
Genomics,Multiomics E-GEOD-23952
2015-08-12 | E-GEOD-23952 | ExpressionAtlas